Evidence map›Paper›PMID 39107572›Full record

ArticleCellular and molecular life sciences : CMLS2024

PIEZO1 targeting in macrophages boosts phagocytic activity and foam cell apoptosis in atherosclerosis.

Shirin Pourteymour, Jingxue Fan, Rakesh Kumar Majhi, Shuyuan Guo, Xin Sun, Zhen Huang, Ying Liu, Hanna Winter, Alexandra Bäcklund, Nikolaos-Taxiarchis Skenteris and 11 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. [Research progress on clinical transformation of Piezo1 in osteoarthritis].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Review
  4. Review
  5. Yoda molecules agonize PIEZO2.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Shirin Pourteymour *Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden. shirin.pourteymour@medisin.uio.no.
Jingxue Fan *Department of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Rakesh Kumar MajhiDepartment of Microbiology, Tumor and Cell Biology, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
Shuyuan GuoDepartment of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Xin SunDepartment of Cardiology, Shenzhen Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen People's Hospital, Shenzhen, People's Republic of China.
Zhen HuangDepartment of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Ying LiuDepartment of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China.
Hanna WinterDepartment of Vascular and Endovascular Surgery, Technical University Munich, Munich, Germany.
Alexandra BäcklundDepartment of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
Nikolaos-Taxiarchis SkenterisDepartment of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
Ekaterina ChernogubovaDepartment of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
Olivera WerngrenDepartment of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
Zhaolong LiDepartment of Vascular and Endovascular Surgery, Technical University Munich, Munich, Germany.
Josefin SkogsbergDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Yuhuang LiDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Ljubica MaticDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Ulf HedinDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Lars MaegdefesselDepartment of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
Ewa EhrenborgDepartment of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
Ye TianDepartment of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University, Harbin, People's Republic of China. yetian@ems.hrbmu.edu.cn.
Hong JinDepartment of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden. hong.jin@ki.se.ORCID http://orcid.org/0000-0002-8878-6436

Funding

H2020 Marie Skłodowska-Curie Actions No 801133Karolinska Institutet Foundation for Geriatric DiseasesNational Key Scientific Instrument and Equipment Development Projects of China 81727809The State Key Program of the National Science Foundation of China 81530053The Young Scientist Fund of the National Natural Science Foundation of China 81701848
6 · The paper itself

Abstract

The rising incidences of atherosclerosis have necessitated efforts to identify novel targets for therapeutic interventions. In the present study, we observed increased expression of the mechanosensitive calcium channel Piezo1 transcript in mouse and human atherosclerotic plaques, correlating with infiltration of PIEZO1-expressing macrophages. In vitro administration of Yoda1, a specific agonist for PIEZO1, led to increased foam cell apoptosis and enhanced phagocytosis by macrophages. Mechanistically, PIEZO1 activation resulted in intracellular F-actin rearrangement, elevated mitochondrial ROS levels and induction of mitochondrial fragmentation upon PIEZO1 activation, as well as increased expression of anti-inflammatory genes. In vivo, ApoE

Indexed as

ApoptosisAtherosclerosisFoam CellsIon ChannelsMacrophagesPhagocytosisAnimalsHumansMaleMiceMice, Inbred C57BLMitochondriaPlaque, AtheroscleroticPyrazinesReactive Oxygen SpeciesThiadiazolesIon ChannelsPIEZO1 protein, humanPiezo1 protein, mousePyrazinesReactive Oxygen SpeciesThiadiazolesThiophenesyoda-1AtherosclerosisMacrophagesMitochondriaPIEZO1Reactive oxygen species

Identifiers

PMID39107572
PMCPMC11335255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.